During the past nine years, the DERC, with its Core Laboratories, Enrichment Program and support for Pilot and Feasibility. studies, has played a major role in allowing for expansion in the scope and intensity of research at the Joslin Diabetes Center and Harvard Medical School. The DERC has provided essential support for interdisciplinary studies and junior faculty, and a critical infrastructure for both basic and clinical research. It is not surprising, therefore, that over his period there has been a further strengthening of the research effort at the Joslin, a significant increase in the publications in peer-reviewed journals and a more than 50% increase in training of research fellows. Recognizing this growth in research activity and the importance of the research mission, the Joslin added three floors to its building with over 30,000 sq. ft. of additional research space, and has renovated research space in the original building, all of which has resulted in improved laboratory space for individual investigators and the DERC Core Laboratories. In this renewal application, we have attempted to build on those strengths by eliminating Core Laboratories which were underutilized (such as Flow Cytometry) and adding new Cores (such as the Computer Resource Core). In addition, we have expanded the scope of the services provided by most Cores, but especially, the Peptide Biochemistry Core, the Microscopy Core, the Radioligand Assay Laboratory for the Clinical Research Core and the Transgenic Animal Core. At the last renewal we added one Pilot and Feasibility grant to our Center for use by scientists in the Longwood area outside the Joslin and affiliated with Harvard hospitals (e.g. Harvard Medical School, Children's Hospital, Beth Israel Hospital, Brigham and Women's Hospital, Deaconess Hospital, Dana Farber Cancer Institute, Center for Blood Research and Massachusetts General Hospital), and this program will continue. Within the DERC and the Joslin we have been particularly encouraged over the past four years by the development of younger faculty who have bean supported directly and indirectly by the DERC, such as Drs. Jackson, White, Hattori, Maratos-Flier, Rhodes, Shoelson, Lipes, Goodyear and others. These individuals, along with more established investigators and new faculty recruited by virtue of expansion, create the scientific base and strength of the Joslin DERC. Finally, the strong intellectual stimulus provided by the activities of the Enrichment Program have a major impact, not only at the Joslin, but in the whole Harvard-Longwood Medical area.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
3P30DK036836-15S4
Application #
6505498
Study Section
Special Emphasis Panel (ZDK1 (08))
Program Officer
Abraham, Kristin M
Project Start
1986-09-30
Project End
2002-03-31
Budget Start
2000-12-01
Budget End
2002-03-31
Support Year
15
Fiscal Year
2001
Total Cost
$145,162
Indirect Cost
Name
Joslin Diabetes Center
Department
Type
DUNS #
071723084
City
Boston
State
MA
Country
United States
Zip Code
02215
Fujisaka, Shiho; Avila-Pacheco, Julian; Soto, Marion et al. (2018) Diet, Genetics, and the Gut Microbiome Drive Dynamic Changes in Plasma Metabolites. Cell Rep 22:3072-3086
Bartelt, Alexander; Widenmaier, Scott B; Schlein, Christian et al. (2018) Brown adipose tissue thermogenic adaptation requires Nrf1-mediated proteasomal activity. Nat Med 24:292-303
Weisman, Alanna; Lovblom, Leif E; Keenan, Hillary A et al. (2018) Diabetes Care Disparities in Long-standing Type 1 Diabetes in Canada and the U.S.: A Cross-sectional Comparison. Diabetes Care 41:88-95
Van Name, Michelle A; Hilliard, Marisa E; Boyle, Claire T et al. (2018) Nighttime is the worst time: Parental fear of hypoglycemia in young children with type 1 diabetes. Pediatr Diabetes 19:114-120
McGill, Dayna E; Volkening, Lisa K; Pober, David M et al. (2018) Depressive Symptoms at Critical Times in Youth With Type 1 Diabetes: Following Type 1 Diabetes Diagnosis and Insulin Pump Initiation. J Adolesc Health 62:219-225
Panduro, Marisella; Benoist, Christophe; Mathis, Diane (2018) Treg cells limit IFN-? production to control macrophage accrual and phenotype during skeletal muscle regeneration. Proc Natl Acad Sci U S A 115:E2585-E2593
Stanford, Kristin I; Goodyear, Laurie J (2018) Muscle-Adipose Tissue Cross Talk. Cold Spring Harb Perspect Med 8:
Katz, Michelle L; Guo, Zijing; Laffel, Lori M (2018) Management of Hypertension and High Low-Density Lipoprotein in Pediatric Type 1 Diabetes. J Pediatr 197:140-146.e12
Yoon, Sujung; Kim, Jungyoon; Musen, Gail et al. (2018) Prefronto-temporal white matter microstructural alterations 20?years after the diagnosis of type 1 diabetes mellitus. Pediatr Diabetes 19:478-485
Altindis, Emrah; Cai, Weikang; Sakaguchi, Masaji et al. (2018) Viral insulin-like peptides activate human insulin and IGF-1 receptor signaling: A paradigm shift for host-microbe interactions. Proc Natl Acad Sci U S A 115:2461-2466

Showing the most recent 10 out of 1120 publications